Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Madsen JS et al. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. 2003 J. Thromb. Haemost. pmid:12941041
Lindgren R et al. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate. 1992 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:1294408
Skarda J Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice. 2003 J Vet Med A Physiol Pathol Clin Med pmid:12948158
Perusquía M et al. Vasodilating effect of norethisterone and its 5 alpha metabolites: a novel nongenomic action. 2003 Eur. J. Pharmacol. pmid:12954372
Boon J et al. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT. 2003 Maturitas pmid:12963171
Illouz S et al. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance. 2003 Int. J. Mol. Med. pmid:12964029
Ylikorkala O et al. Effects of hormone therapy and alendronate on C-reactive protein, E-selectin, and sex hormone-binding globulin in osteoporotic women. 2003 Fertil. Steril. pmid:12969695
Bellmann O et al. In vitro studies on enzymatic cleavage of steroid esters in the female organism. 1976 Acta Endocrinol. pmid:130782
Huovinen KJ et al. Lynestrenol induced therapeutic amenorrhea: effects of dose reduction on serum sex-hormones and lipids. 1992 Acta Obstet Gynecol Scand pmid:1317638
Stokes GS et al. Effects of oral contraceptives containing oestrogen combined with norethisterone or levonorgestrel on erythrocyte cation transport in normal women. 1992 Clin. Sci. pmid:1317759
Aoki T [The preventive effect of HRT on postmenopausal bone loss]. 1992 Nippon Sanka Fujinka Gakkai Zasshi pmid:1320084
Myrup B et al. Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. 1992 Arch. Intern. Med. pmid:1332634
Tadmor OP et al. The effects of two fixed hormonal replacement therapy protocols on blood lipid profile. 1992 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:1333421
Ambrus JL et al. Progestational agents and blood coagulation. VII. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study. 1976 Am. J. Obstet. Gynecol. pmid:133615
Saure A et al. The effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of early pregnancy. 1976 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:135698
Le Bail B et al. Liver adenomatosis with granulomas in two patients on long-term oral contraceptives. 1992 Am. J. Surg. Pathol. pmid:1357995
Tadmor OP et al. The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women. 1992 Int J Gynaecol Obstet pmid:1358708
Manusharova RA [The treatment of the climacteric syndrome in women suffering from Itsenko-Cushing disease and primary obesity]. 1992 Lik. Sprava pmid:1364624
APOSTOLAKIS M The effect of oral administration of norethisterone in oligospermic males. 1961 Acta Endocrinol. pmid:13683851
FOSS GL Clinical experience with norethisterone and norethisterone acetate. 1960 Br Med J pmid:13700943
JACOBSON BD Abortion: its prediction and management. Clinical experience with Norlutin. 1961 Sep-Oct Fertil. Steril. pmid:13718595
Voigt R et al. [Urographic investigations on the effect of high dose progestagen therapy (author's transl)]. 1976 Rofo pmid:137193
DAVIDSMEYER I and BOLDINO G [The possibility of inhibition of lactation with norethisterone (17 alpha-ethinyl-19-nortestosterone)]. 1960 Dtsch. Med. Wochenschr. pmid:13720035
PARADA J et al. The effect of norethisterone on anterior pituitary function, steroid metabolism and basal temperature in males. 1960 Acta Endocrinol. pmid:13732715
LANGECKER H [The metabolite in the human urine after the administration of 17 alpha-ethynyl-19-nortestosterone (norethisterone)]. 1961 Acta Endocrinol. pmid:13758822
MIYAKE T and KOBAYASHI F Effects of norethisterone (17alpha-ethynyl-19-nortestosterone) and certain other steroids on the female gonads of hypophysectomized immature rats. 1960 Endocrinol. Jpn. pmid:13771486
TYLER ET et al. An oral contraceptive. A 4-year study of norethindrone. 1961 Obstet Gynecol pmid:13778871
JENKINS JS Progesterone and norethisterone in cyclical oedema and ascites. 1961 Br Med J pmid:13789834
BISHOP PM and CABRAL DE ALMEIDA JC Treatment of functional menstrual disorders with norethisterone. 1960 Br Med J pmid:13800996
BROWN JB et al. The effect of 17alpha-ethinyl-19-nortestosterone (norethisterone) on the urinary excretion of oestrogens, pregnanediol and gonadotrophins during the menstrual cycle. 1960 Proc. R. Soc. Med. pmid:13804952
DOUGLAS M et al. Studies with 19-norethisterone oenanthate in mammary carcinoma. 1960 Proc. R. Soc. Med. pmid:13817831
APPLEBY B Norethisterone in the control of menopausal symptoms. 1962 Lancet pmid:13861933
Surrey ES and Judd HL Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. 1992 J. Clin. Endocrinol. Metab. pmid:1386374
Cullins VE Injectable and implantable contraceptives. 1992 Curr. Opin. Obstet. Gynecol. pmid:1387011
GOLDZIEHER JW et al. Study of norethindrone in contraception. 1962 JAMA pmid:13899932
SCOTT RB and WHARTON LR Effects of progesterone and norethindrone on experimental endometriosis in monkeys. 1962 Am. J. Obstet. Gynecol. pmid:13909977
LIN TJ and HALEY ME Supportive therapy in idiopathic thrombocytopenic purpura with menorrhagia. Report of a case. 1963 Obstet Gynecol pmid:13930703
PAULSEN CA et al. Inherent estrogenicity of norethindrone and norethynodrel: comparison with other synthetic progestins and progesterone. 1962 J. Clin. Endocrinol. Metab. pmid:13942007
PEREZ-MERA RA and SHIELDS CE Jaundice associated with norethindrone acetate therapy. 1962 N. Engl. J. Med. pmid:13942388
GREENSTEIN NM Iatrogenic female pseudohermaphroditism. 1962 Jew Mem Hosp Bull pmid:13950206
HEINEN G [Oral contraception]. 1962 Med Welt pmid:13953432
HELPAP B [On the management of endometriosis with ethynyl nortestosterone acetate]. 1963 Geburtshilfe Frauenheilkd pmid:13953657
JACOBSON BD Hazards of northindrome therapy during pregnancy. 1962 Am. J. Obstet. Gynecol. pmid:13964346
BETTENDORF G [Control of hypogonadotropic ovarian insufficiency with human pituitary gonadotropin]. 1962 Geburtshilfe Frauenheilkd pmid:13967836
BETZ G and WARREN JC Hydrolysis of norethindrone acetate by fetal and placental tissue. 1963 N. Engl. J. Med. pmid:13967871
BHAGAT B and SHIKEMAN FE Mechanism of the inhibitory action of guanethidine on cardiovascular responses to tyramine and amphetamine. 1963 J. Pharmacol. Exp. Ther. pmid:13967970
REIFENSTEIN EC et al. Oral hormone (Gestest) diagnostic test for early pregnancy. 1963 Jan-Feb Fertil. Steril. pmid:13973779
RINGROSE CA Current concepts in conception control. 1963 Can Med Assoc J pmid:13973987
SHEARMAN RP Excretion of ovarian steroids in patients treated with an "ovulation inhibitor". 1963 Lancet pmid:13977013
SNAITH L Long-term progestogen therapy in endometriosis. 1962 J Obstet Gynaecol Br Emp pmid:13989665